ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01XX44 | BioTech | Aflibercept - 100mg/4ml | 7586 | 186625/13 | ZALTRAP | 100mg/4ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 35,658,713 L.L | 19.35 | D | Sanofi Aventis Groupe | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01XX44 | BioTech | Aflibercept - 100mg/4ml | 11806 | 109123/1 | ZALTRAP | 100mg/4ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 35,658,713 L.L | 19.35 | D | Sanofi Winthrop Industrie | France | 2/5/2024 | 0 |